Assimes TL, Roberts R. Genetics: implications for prevention and management of coronary artery disease. J Am Coll Cardiol. 2016;68(25):2797–818.
Article
CAS
PubMed
Google Scholar
Bjorkegren JLM, Kovacic JC, Dudley JT, Schadt EE. Genome-wide significant loci: how important are they? Systems genetics to understand heritability of coronary artery disease and other common complex disorders. J Am Coll Cardiol. 2015;65(8):830–45.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33.
Article
CAS
PubMed
Google Scholar
McPherson R, Tybjaerg-Hansen A. Genetics of coronary artery disease. Circ Res. 2016;118(4):564–78.
Article
CAS
PubMed
Google Scholar
Ozaki K, Tanaka T. Molecular genetics of coronary artery disease. J Hum Genet. 2016;61(1):71–7.
Article
CAS
PubMed
Google Scholar
Roberts R. Genetics of coronary artery disease. Circ Res. 2014;114(12):1890–903.
Article
CAS
PubMed
Google Scholar
Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A. 2001;98(10):5780–5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kendall RL, Thomas KA. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci U S A. 1993;90(22):10705–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med. 2001;7(5):575–83.
Article
CAS
PubMed
Google Scholar
Kurotsu S, Osakabe R, Isomi M, Tamura F, Sadahiro T, Muraoka N, et al. Distinct expression patterns of Flk1 and Flt1 in the coronary vascular system during development and after myocardial infarction. Biochem Biophys Res Commun. 2018;495(1):884–91.
Article
CAS
PubMed
Google Scholar
Rajakumar A, Powers RW, Hubel CA, Shibata E, von Versen-Hoynck F, Plymire D, et al. Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women. Placenta. 2009;30(1):25–34.
Article
CAS
PubMed
Google Scholar
Zentilin L, Puligadda U, Lionetti V, Zacchigna S, Collesi C, Pattarini L, et al. Cardiomyocyte VEGFR-1 activation by VEGF-B induces compensatory hypertrophy and preserves cardiac function after myocardial infarction. FASEB J. 2010;24(5):1467–78.
Article
CAS
PubMed
Google Scholar
Seno A, Takeda Y, Matsui M, Okuda A, Nakano T, Nakada Y, et al. Suppressed production of soluble Fms-like tyrosine Kinase-1 contributes to myocardial remodeling and heart failure. Hypertension. 2016;68(3):678–87.
Article
CAS
PubMed
Google Scholar
Shibuya M. Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis. Angiogenesis. 2006;9(4):225–30. discussion 31
Article
CAS
PubMed
Google Scholar
Di Marco GS, Kentrup D, Reuter S, Mayer AB, Golle L, Tiemann K, et al. Soluble Flt-1 links microvascular disease with heart failure in CKD. Basic Res Cardiol. 2015;110(3):30.
Article
PubMed
CAS
Google Scholar
Hammadah M, Georgiopoulou VV, Kalogeropoulos AP, Weber M, Wang X, Samara MA, et al. Elevated soluble Fms-like tyrosine Kinase-1 and placental-like growth factor levels are associated with development and mortality risk in heart failure. Circ Heart Fail. 2016;9(1):e002115.
Article
CAS
PubMed
Google Scholar
Kaza E, Ablasser K, Poutias D, Griffiths ER, Saad FA, Hofstaetter JG, et al. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium. Cardiovasc Res. 2011;89(2):410–8.
Article
CAS
PubMed
Google Scholar
Kodama Y, Kitta Y, Nakamura T, Takano H, Umetani K, Fujioka D, et al. Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. J Am Coll Cardiol. 2006;48(1):43–50.
Article
CAS
PubMed
Google Scholar
Ky B, French B, Ruparel K, Sweitzer NK, Fang JC, Levy WC, et al. The vascular marker soluble fms-like tyrosine kinase 1 is associated with disease severity and adverse outcomes in chronic heart failure. J Am Coll Cardiol. 2011;58(4):386–94.
Article
CAS
PubMed
PubMed Central
Google Scholar
Matsui M, Takeda Y, Uemura S, Matsumoto T, Seno A, Onoue K, et al. Suppressed soluble Fms-like tyrosine kinase-1 production aggravates atherosclerosis in chronic kidney disease. Kidney Int. 2014;85(2):393–403.
Article
CAS
PubMed
Google Scholar
Onoue K, Uemura S, Takeda Y, Somekawa S, Iwama H, Imagawa K, et al. Reduction of circulating soluble fms-like tyrosine kinase-1 plays a significant role in renal dysfunction-associated aggravation of atherosclerosis. Circulation. 2009;120(24):2470–7.
Article
CAS
PubMed
Google Scholar
Wang Y, Zhou Y, He L, Hong K, Su H, Wu Y, et al. Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque. Clin Exp Med. 2011;11(2):113–21.
Article
PubMed
CAS
Google Scholar
Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res. 2004;95(9):884–91.
Article
CAS
PubMed
Google Scholar
Hochholzer W, Reichlin T, Stelzig C, Hochholzer K, Meissner J, Breidthardt T, et al. Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction. Eur Heart J. 2011;32(3):326–35.
Article
CAS
PubMed
Google Scholar
Sandelin A, Alkema W, Engström P, Wasserman WW, Lenhard B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 2004;32(Database issue):D91–4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Willcox BJ, Morris BJ, Tranah GJ, Chen R, Masaki KH, He Q, et al. Longevity-associated FOXO3 genotype and its impact on coronary artery disease mortality in Japanese, whites, and blacks: a prospective study of three American populations. J Gerontol A Biol Sci Med Sci. 2017;72(5):724–8.
CAS
PubMed
Google Scholar
Graziani G, Ruffini F, Tentori L, Scimeca M, Dorio AS, Atzori MG, et al. Antitumor activity of a novel anti-vascular endothelial growth factor receptor-1 monoclonal antibody that does not interfere with ligand binding. Oncotarget. 2016;7(45):72868–85.
Article
PubMed
PubMed Central
Google Scholar
Qiu Y, Chen C, Zhang J, Chen M, Gong H, Gong L, et al. VEGF attenuates lung injury by inducing homing of CD133(+) progenitors via VEGFR1. Biochem Biophys Res Commun. 2019;511(3):650–7.
Article
CAS
PubMed
Google Scholar
Das V, Kc R, Li X, OS I, van Wijnen AJ, Kroin JS, et al. Blockade of vascular endothelial growth factor receptor-1 (Flt-1), reveals a novel analgesic for osteoarthritis-induced joint pain. Gene Rep. 2018;11:94–100.
Article
PubMed
PubMed Central
Google Scholar
Deepak V, Sahu MB, Yu J, Jones JW, Kane MA, Taylor RN, et al. Retinoic acid is a negative regulator of sFLT1 expression in decidual stromal cells, and its levels are reduced in preeclamptic decidua. Hypertension. 2019; https://doi.org/10.1161/Hypertensionaha11812564.
Gerber HP, Condorelli F, Park J, Ferrara N. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia. J Biol Chem. 1997;272(38):23659–67.
Article
CAS
PubMed
Google Scholar
Shima DT, Deutsch U, D'Amore PA. Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Lett. 1995;370(3):203–8.
Article
CAS
PubMed
Google Scholar
Leonard F, Devaux Y, Vausort M, Ernens I, Rolland-Turner M, Wagner DR. Adenosine modifies the balance between membrane and soluble forms of Flt-1. J Leukoc Biol. 2011;90(1):199–204.
Article
CAS
PubMed
Google Scholar
Ahn A, Frishman WH, Gutwein A, Passeri J, Nelson M. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease—part II. Cardiol Rev. 2008;16(5):219–29.
Article
PubMed
Google Scholar
Boodhwani M, Sodha NR, Laham RJ, Sellke FW. The future of therapeutic myocardial angiogenesis. Shock. 2006;26(4):332–41.
Article
CAS
PubMed
Google Scholar
Nelson MA, Passeri J, Frishman WH. Therapeutic angiogenesis: a new treatment modality for ischemic heart disease. Heart Dis. 2000;2(4):314–25.
CAS
PubMed
Google Scholar
Pandya NM, Dhalla NS, Santani DD. Angiogenesis—a new target for future therapy. Vasc Pharmacol. 2006;44(5):265–74.
Article
CAS
Google Scholar
Clayton JA, Chalothorn D, Faber JE. Vascular endothelial growth factor-a specifies formation of native collaterals and regulates collateral growth in ischemia. Circ Res. 2008;103(9):1027–36.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kocaman SA, Arslan U, Tavil Y, Okuyan H, Abaci A, Cengel A. Increased circulating monocyte count is related to good collateral development in coronary artery disease. Atherosclerosis. 2008;197(2):753–6.
Article
CAS
PubMed
Google Scholar
Lahteenvuo JE, Lahteenvuo MT, Kivela A, Rosenlew C, Falkevall A, Klar J, et al. Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms. Circulation. 2009;119(6):845–56.
Article
PubMed
CAS
Google Scholar
Matsudaira K, Maeda K, Okumura N, Yoshikawa D, Morita Y, Mitsuhashi H, et al. Impact of low levels of vascular endothelial growth factor after myocardial infarction on 6-month clinical outcome. Results from the Nagoya Acute Myocardial Infarction Study. Circ J. 2012;76(6):1509–16.
Article
CAS
PubMed
Google Scholar
Taniguchi T, Sawada T. Significance of measuring plasma vascular endothelial growth factor in patients with acute myocardial infarction. Circ J. 2012;76(6):1331–2.
Article
CAS
PubMed
Google Scholar
Tokgozoglu L, Yorgun H, Gurses KM, Canpolat U, Ates AH, Tulumen E, et al. The association between circulating endothelial progenitor cells and coronary collateral formation. Atherosclerosis. 2011;219(2):851–4.
Article
PubMed
CAS
Google Scholar
Hiratsuka S, Minowa O, Kuno J, Noda T, Shibuya M. Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci U S A. 1998;95(16):9349–54.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bry M, Kivela R, Leppanen VM, Alitalo K. Vascular endothelial growth factor-B in physiology and disease. Physiol Rev. 2014;94(3):779–94.
Article
CAS
PubMed
Google Scholar
Dewerchin M, Carmeliet P. PlGF: a multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med. 2012;2(8).
Article
PubMed
PubMed Central
CAS
Google Scholar
Autiero M, Waltenberger J, Communi D, Kranz A, Moons L, Lambrechts D, et al. Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med. 2003;9(7):936–43.
Article
CAS
PubMed
Google Scholar
Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci. 2002;115(Pt 12):2559–67.
CAS
PubMed
Google Scholar